Floatz logo

ALENDRONIC ACID

HIV Infections

French National Agency for Research on AIDS and Viral HepatitisSmall moleculePhase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
81/ 100

Competitive context

62 Active assets in the HIV Infections cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
Efavirenz
The Cleveland Clinic
Phase 4BBB
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Abacavir
Germans Trias i Pujol Hospital
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 50 →

Same molecule, other indications

ALENDRONIC ACID is also rated in:

osteoporosisDormant
BBB
Indicative ·
75 / 100
View asset →
osteoporosisDormant
BB
Indicative ·
64 / 100
View asset →
metabolic bone disorderDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →